atai and Beckley Psytech plan to meet with the U.S. Food and Drug Administration (FDA) and other regulatory agencies to finalize the Phase 3 trial design.
This collaboration ensures that patients receive comprehensive care, including emotional and psychological support throughout their fertility journey
Launches FSSAI’s inclusive campaign to stop obesity with multilingual, sign language outreach and multi-platform media engagement under Eat Right India programme
Approximately 35% of male cancer patients and 12% of female cancer patients at Paras Health were diagnosed with tobacco-related cancers
USFDA inspection at Alembic Pharma's Bioequivalence facility
Inaugurates new facilities to further NIMHANS’ mission of delivering cutting-edge care in mental health and neurosciences
Parents, teachers, and caregivers play a vital role in spotting early signs of schizophrenia
The company will also share results in two additional posters for deuruxolitinib
Report highlights significant improvements in adolescent well-being in India
Subscribe To Our Newsletter & Stay Updated
